| Schedule of shares issued |
| | | | | | | | Number of | | | Common Shares | | Shares | | Stated Value | Balance, September 30, 2024 | | 18,271,711 | | $ | 17,256,668 | Shares issued for acquisitions | | 1,283,849 | | | 22,330,215 | Conversions of Notes into common shares | | 1,147,806 | | | 13,247,405 | Exercise of options | | 1,698,476 | | | 3,120,672 | Exercise of warrants | | 452,333 | | | 11,219,562 | Exercise of RSUs | | 124,103 | | | 2,882,142 | Interest paid with common shares | | 21,563 | | | 371,891 | Balance, September 30, 2025 | | 22,999,841 | | $ | 70,428,555 | Shares issued for LIFE Offering (Stated Value net of warrant allocation) | | 4,380,000 | | | 12,091,000 | Equity issuance costs | | — | | | (3,212,059) | Shares issued for acquisitions | | 920,549 | | | 4,811,779 | Conversions of Notes into common shares | | 290,094 | | | 1,259,276 | Balance, December 31, 2025 | | 28,590,484 | | $ | 85,378,551 |
|
| Schedule of basic and diluted earnings per share |
| | | | | | | Three-months ended December 31, | | 2025 | | 2024 | Net income for the period | | $ | (11,846,638) | | $ | 3,225,716 | Weighted average number of shares outstanding | | | 27,672,720 | | | 18,406,149 | Earnings per share, basic | | $ | (0.43) | | $ | 0.18 | | | | | | | | Weighted average number of shares outstanding | | | 27,672,720 | | | 18,406,149 | Share based compensation dilution | | | — | | | 1,646,652 | Weighted average number of shares outstanding, diluted | | | 27,672,720 | | | 20,052,801 | Earnings per share, diluted | | $ | (0.43) | | $ | 0.16 |
|